All lobbying filings

COALITION FOR HEALTHCARE COMMUNICATIONS

Lobbying for COALITION FOR HEALTHCARE COMMUNICATIONS · Healthcare Advertising, Communications, Publishing

Filing · LD-2 quarterly report Q1 report

Reporting period

1st Quarter 2026

Jan 1 - Mar 31 · Posted May 4, 2026

Money reported

None

Registrations and no-activity reports carry no figure.

Client based in

New York

Official filing document

Lobbying activity 1

Health Issues

S.483 (HR 1117) - Responsibility in Drugs Advertising Act S.229 - Drug Pricing Transparency for Consumers Act S.1785 (HR 3010) - No Handouts for Drug Advertising Act S.2068 (HR 4605) - End Prescription Drug Ads Now

Bills named in this filing 7

S. 483
Responsibility in Drug Advertising Act of 2025
H.R. 1117
Responsibility in Drug Advertising Act of 2025
S. 229
DTC Act of 2025
S. 1785
No Handouts for Drug Advertisements Act
H.R. 3010
No Handouts for Drug Advertisements Act
S. 2068
End Prescription Drug Ads Now Act
H.R. 4605
End Prescription Drug Ads Now Act

Source: federal Lobbying Disclosure Act filing, reproduced as filed. Bills are parsed from the activity descriptions.